8173
We present the management of agranulocytosis and neutropenic sepsis secondary to carbimazole with recombinant human granulocyte colony stimulating factor ( G - CSF ) .
 adverse effect: agranulocytosis, carbimazole; adverse effect: neutropenic sepsis, carbimazole
Given options, please tell me the relationships of all the listed entity pairs.Output format is "relation1: word1, word2; relation2: word3, word4". 
Option: adverse effect 
Text: {0} 
 Entity Pairs:  agranulocytosis, carbimazole; neutropenic sepsis, carbimazole 
Answer:
 adverse effect: agranulocytosis, carbimazole; adverse effect: neutropenic sepsis, carbimazole